News

R-Biopharm AG today announced that it has entered into a collaboration with Bosch Healthcare Solutions. Under the agreement, R‑Biopharm AG develops, manufactures and commercializes molecular diagnostic tests for Bosch Healthcare Solutions’ Vivalytic, a fully automatic all-in-one platform. The [...]

R-Biopharm AG announced today it has entered into an agreement with UgenTec to collaborate on developing interpretation software for R-Biopharm’s clinical PCR (Polymerase Chain Reaction) kits. Under the agreement, UgenTec will develop standardized software for automated quantitative result [...]

To improve clinical guidance in the therapy of diseases, official treatment recommendations are provided in Switzerland. These are comparable to medical guidelines in Germany. In 2016, the treatment recommendations for the acute treatment of depressive episodes were revised by the Swiss Society [...]

New approach in depression treatment Globally, over 300 million people suffer from depression. Thus depression is the most common mental disorder. Affected patients have symptoms of sadness, worthlessness and guilt and are severely impaired in their quality of life. At its worst, depression can [...]

Apply for our advanced training program psychopharmacology – new ways in depression therapy. The program includes talks and is designed for physicians and psychiatrists only. Discuss with our experts the progress in depression therapy today. See our invitation.

R-Biopharm AG announced today it has entered into a collaboration agreement with HMNC Brain Health in the field of complementary diagnostics. Under this agreement R-Biopharm AG will develop an in vitro PCR (Polymerase Chain Reaction) based genetic test. The goal is to identify ABCB1 gene [...]

R-Biopharm AG announced today it has entered into an agreement with Merck KGaA, Darmstadt, Germany to collaborate on developing companion diagnostics. The agreement constitutes the first collaboration between the two companies, covering research, development and launching of novel companion [...]

R-Biopharm AG, one of the world’s leading suppliers of reliable test systems for clinical diagnostics is taking over the business operations of GeneWake GmbH and reinforcing its field of Companion Diagnostics. R-Biopharm AG has many years of experience in the development of test systems for [...]

Since September 2015 the Darmstadt-based diagnostic company R-Biopharm AG is a new partner of InfectoGnostics Research Campus. The medium-sized company is the first InfectoGnostics partner outside of Thuringia. The aim of the partnership is a close cooperation in the fields of clinical [...]

R-Biopharm strengthens its position in the field of companion diagnostics Cooperation represents a further endorsement of R-Biopharm’s companion diagnostic technologies R-Biopharm AG, a global provider of innovative clinical diagnostics, announced today that it has entered into a research and [...]